Improvement of Asthma Management in Actual Practice Consistent with Prevalence of Anti-inflammatory Agents—Based on Questionnaire Surveys in Niigata Prefecture, Japan from 1998 to 2002—
-
- Hasegawa Takashi
- Division of Respiratory Medicine, Niigata University Graduate School of Medical and Dental Sciences Niigata Asthma Treatment Study Group
-
- Suzuki Eiichi
- Department of General Medicine, Niigata University Hospital Niigata Asthma Treatment Study Group
-
- Terada Masaki
- Division of Respiratory Medicine, Niigata University Graduate School of Medical and Dental Sciences
-
- Koya Toshiyuki
- Division of Respiratory Medicine, Niigata University Graduate School of Medical and Dental Sciences
-
- Toyabe Shinichi
- Department of Medical Information Science, Niigata University Hospital
-
- Akazawa Kohei
- Department of Medical Information Science, Niigata University Hospital
-
- Yoshizawa Hirohisa
- Division of Respiratory Medicine, Niigata University Graduate School of Medical and Dental Sciences
-
- Arakawa Masaaki
- Division of Respiratory Medicine, Niigata University Graduate School of Medical and Dental Sciences Niigata Asthma Treatment Study Group
-
- Gejyo Fumitake
- Division of Respiratory Medicine, Niigata University Graduate School of Medical and Dental Sciences Niigata Asthma Treatment Study Group
書誌事項
- タイトル別名
-
- Improvement of Asthma Management in Actual Practice Consistent with Prevalence of Anti-inflammatory Agents-Based on Questionnaire Surveys in Niigata Prefecture, Japan from 1998 to 2002-
この論文をさがす
抄録
Background: Because bronchial inflammation was recognized as a basic component of bronchial asthma, the strategy for asthma management has changed in the last two decades. In Japan there are few clinico-epidemiological reports of changes in the management of bronchial asthma in actual practice.<br> In this study, we analyzed practical asthma management in Japan, and examined changes in the prevalence of asthma medication and relation between these changes and the level of asthma control and management.<br> Methods: From 1998 to 2002, questionnaires on asthma control, asthma related emergent episodes and satisfaction in daily life. Questionnaires were distributed to adult asthmatic patients. Questionnaires about the patients' profiles and medication were also given to the patients' doctors.<br> Results: The total number of patient responders was approximately 2500—3300 per year. The rate of peak flow meter (PEFM) use was under approximately only 40% and plateaued from 2000 to 2002. The percentage of inhaled corticosteroid use and leukotriene receptor antagonist use increased, from 62.0%, 27.2% to 77.4%, 40.6% respectively. Indicators for asthma control, including presence of attacks and sleep disturbance, were significantly improved. Limited to PEFM users, there was an improvement hospitalization, ambulance use or ED visits and in satisfaction in daily life based on a Quality of Life (QOL) indicator.<br> Conclusions: These results indicate that the prevalence of anti-inflammatory agents, including inhaled corticosteroids and leukotriene receptor antagonist, was associated with an adequate improvement in asthma control in clinical practice. In asthma management in clinical practice, prevalence of PEFM may play an important role in the improvement of asthma related emergent episodes or QOL.<br>
収録刊行物
-
- Allergology International
-
Allergology International 54 (4), 555-563, 2005
一般社団法人日本アレルギー学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001204634259712
-
- NII論文ID
- 130004476865
- 10016880773
-
- NII書誌ID
- AA11091750
-
- ISSN
- 14401592
- 13238930
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可